Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial

NCT01303614 is registered in ClinicalTrials.gov with Consorci Sanitari de Terrassa as lead sponsor.

NCT NCT01303614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01303614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice: a Prospective Randomized Double Blind, Placebo-controlled Clinical Trial
Lead sponsor
Consorci Sanitari de Terrassa
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2011
Completion date
September 30, 2012
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gynecological pathology